Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients

Chronic hepatitis B (CHB) infection functional cure is defined as sustained loss of HBsAg and several therapeutic strategies are in clinical development designed to pharmacologically reduce serum HBsAg, break immune tolerance, and increase functional cure rates. However, little is known about pre-tr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sci Rep
Autori principali: Kim, Jin Hyang, Ghosh, Alip, Ayithan, Natarajan, Romani, Sara, Khanam, Arshi, Park, Jang-June, Rijnbrand, Rene, Tang, Lydia, Sofia, Michael J., Kottilil, Shyam, Moore, Chris B., Poonia, Bhawna
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7000714/
https://ncbi.nlm.nih.gov/pubmed/32020034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-58870-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi